Answer
Yescarta (axicabtagene ciloleucel) has very commonly caused severe neurological reactions called immune effector cell-associated neurotoxicity syndrome (ICANS), potentially life-threatening or fatal, and serious or fatal cerebral oedema, mostly with ICANS; cerebral oedema risk may be higher in primary mediastinal large B-cell lymphoma.
Sources for this answer
- YESCARTAGilead Sciences Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 19Document updated
Sources checked